WVE Wave Life Sciences Ltd

Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.

$6.14  +0.33 (5.59%)
As of 05/12/2021 15:59:35 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Singapore
IPO date:  11/11/2015
Outstanding shares:  49,855,763
Average volume:  731,933
Market cap:   $300,131,693
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    Y95308105
ISIN:        SG9999014716
Sedol:      BYZG9R0
Valuation   (See tab for details)
PE ratio:   -1.93
PB ratio:   3.42
PS ratio:   14.95
Return on equity:   -181.10%
Net income %:   -746.68%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy